Intended for healthcare professionals

Editorials

Avoiding rabies

BMJ 2005; 331 doi: https://doi.org/10.1136/bmj.331.7515.469 (Published 01 September 2005) Cite this as: BMJ 2005;331:469
  1. Derrick Pounder, professor of forensic medicine (d.j.pounder{at}dundee.ac.uk)
  1. Department of Forensic Medicine, University of Dundee, Dundee DD1 4HN

    Get vaccinated before travel, avoid animals, and get help urgently if bitten

    The death from rabies of a British woman, bitten by a dog in Goa, reported in the news1 and in an article in this week's BMJ,2 highlights the issue of rabies prophylaxis for people who travel to and live in endemic areas. Rabies is an acute, incurable, viral encephalomyelitis caused by a bullet shaped RNA rhabdovirus.3 It is a zoonosis, an animal disease that is transmissible to humans. Worldwide, most of the 30 000 to 70 000 human deaths annually result from dog bites, although cats and wild animals such as foxes, jackals, wolves, mongooses, racoons, skunks, and bats are the other culprits.4 5

    Around 90% of deaths from rabies occur in the developing world, with more than half in the Indian subcontinent, where dogs that roam freely are largely responsible. The virus is transmitted through a transdermal bite or scratch, or by contamination with animal saliva of oral mucosa or skin wounds. The incubation period is variable but is typically from one to three months,4 after which clinical symptoms appear and a fatal outcome is almost inevitable. Since rabies cannot be treated, prevention and prophylaxis are paramount.

    Vaccination before exposure does not eliminate the need for treatment after rabies exposure,58 but it simplifies treatment and may provide protection after unrecognised exposure. Currently available rabies vaccines containing inactivated virus derived through tissue culture are safe and effective. For prophylaxis before exposure, three doses of vaccine are given into the deltoid muscle on days 0, 3, and 28, and boosters can be given between six and 24 months. Prophylaxis after exposure aims to neutralise the virus before it can enter the nervous system and entails wound cleaning, passive immunisation with immunoglobulin, and active immunisation with vaccine.58 People who have completed a course of pre-exposure vaccination do not require immunoglobulin and need fewer doses of vaccine in their prophylaxis regimen after exposure: such treatment is effective in preventing the development of rabies if the recommended regimen is followed.

    Wound care is essential to prevent rabies infection. The wound needs to be thoroughly scrubbed with soap and water, or, if available, iodine solution, 40-70% alcohol, cetrimide 0.1% or a similar compound, or the virucidal agent povidone, all under local anaesthesia if possible. The rabies virus is killed by sunlight, drying, soap, and the other agents mentioned. In animal experiments, early effective wound cleaning has been shown to prevent rabies infection.9

    Immunisation is a medical urgency after wound cleaning, although not a medical emergency.58 It should be administered within 24 hours of exposure if at all possible. Rabies immunoglobulin provides rapid, passive immunity for a short time in a previously unvaccinated patient until vaccination has had time to prompt an active immune response. Immunoglobulin should be given as a single dose and infiltrated around the wound if feasible. In the developed world, human rabies immunoglobulin is the standard, but it is very expensive and not commonly available in developing countries, where equine rabies immunoglobulin may be used instead.7 Equine immunoglobulin may, however, cause an allergic reaction. A previously vaccinated patient does not require immunoglobulin and so does not face the difficulty of obtaining it in a developing country.

    People who have not been vaccinated before should have post-exposure vaccination of four to five doses over four weeks, but those previously vaccinated can have boosters only on days 0 and 3.58 In India, cheaper rabies vaccines derived from sheep brains are sometimes still used instead of the safer cell culture vaccines.10 Sheep brain vaccines carry a risk of serious adverse effects, such as neuritis and encephalitis. The cost of both pre-exposure and post-exposure vaccination with cell culture vaccines can be more than halved by giving a lower dose intradermally, rather than intramuscularly, but this requires greater technical skill.11

    Sadly, those at greatest risk of contracting rabies from dog bites are children living in regions of the developing world where rabies is endemic.12 For travellers to those regions, particularly to remote rural areas, making a decision on pre-exposure rabies vaccination requires an assessment of the risk of being bitten and needing treatment,13 and of local access to safe and effective rabies immunoglobulin and vaccines. In many countries of Africa, Asia, Latin America, and the Middle East, dog rabies is common.

    The probability of contact with an infected animal depends in part on anticipated activities, locality, and length of time spent in the country. For example, hiking in a rural area of the Indian subcontinent where dogs commonly roam free carries a sufficient risk of exposure—combined with potential difficulties in obtaining early, safe, and effective post-exposure prophylaxis—to warrant vaccination before travelling.5 The risk can be reduced by avoiding contact with animals that might be susceptible to rabies. Ignoring freely roaming dogs and cats may go against the instincts of animal loving travellers to developing countries but is a necessary precaution. Wildlife should be appreciated at a distance.

    Footnotes

    • Clinical review p 501

    • Competing interests None declared.

    References

    1. 1.
    2. 2.
    3. 3.
    4. 4.
    5. 5.
    6. 6.
    7. 7.
    8. 8.
    9. 9.
    10. 10.
    11. 11.
    12. 12.
    13. 13.